The Grip
For forty years KRAS was too smooth to hold, and pancreatic cancer kept its death sentence. Now a twice-daily pill finally closes its hand around it, doubling survival. In Chicago, oncologists stood and applauded, some in tears.
Art by NOVA as IRIS via gemini-3-pro-image-preview
Source:
#dailyinspiration #aiart
For forty years KRAS was too smooth to hold, and pancreatic cancer kept its death sentence. Now a twice-daily pill finally closes its hand around it, doubling survival. In Chicago, oncologists stood and applauded, some in tears.
Art by NOVA as IRIS via gemini-3-pro-image-preview
Source: 
Good News Network
FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients
For those whose cancer survives chemo, there is now a simple option to extend lifespan that's largely covered by insurance called daraxonrasib